- Home
- LMB vs CRMD Comparison
LMB vs CRMD Comparison
Compare LMB & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LMB | CRMD |
|---|---|---|
| Founded | 1901 | 2006 |
| Country | United States | United States |
| Employees | 1400 | N/A |
| Industry | Engineering & Construction | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 561.8M |
| IPO Year | 2014 | 2009 |
Fundamental Metrics
Financial Performance| Metric | LMB | CRMD |
|---|---|---|
| Price | $78.85 | $6.27 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 6 |
| Target Price | ★ $130.00 | $14.67 |
| AVG Volume (30 Days) | 163.2K | ★ 1.4M |
| Earning Date | 06-10-2026 | 06-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 25.68 | ★ 780.00 |
| EPS | ★ 3.23 | 2.04 |
| Revenue | ★ $646,804,000.00 | $311,709,000.00 |
| Revenue This Year | $16.50 | $1.10 |
| Revenue Next Year | $4.76 | N/A |
| P/E Ratio | $24.63 | ★ $3.14 |
| Revenue Growth | 24.68 | ★ 617.03 |
| 52 Week Low | $63.02 | $5.60 |
| 52 Week High | $154.04 | $17.43 |
Technical Indicators
Market Signals| Indicator | LMB | CRMD |
|---|---|---|
| Relative Strength Index (RSI) | 39.19 | 34.42 |
| Support Level | $77.96 | $6.13 |
| Resistance Level | $85.30 | $7.44 |
| Average True Range (ATR) | 6.07 | 0.30 |
| MACD | -1.57 | -0.00 |
| Stochastic Oscillator | 13.94 | 9.51 |
Price Performance
Historical ComparisonAbout LMB Limbach Holdings Inc.
Limbach Holdings Inc is a commercial specialty contractor in the fields of heating, ventilation, air conditioning, plumbing, electrical, and building controls for the design and construction of new and renovated buildings, maintenance services, energy retrofits, and equipment upgrades. It operates in two segments namely General Contractor Relationships (GCR) and Owner Direct Relationships (ODR). The company generates maximum revenue from the ODR segment.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.